Article Text

Download PDFPDF

CASE REPORT
Acute renal artery infarction secondary to dysfibrinogenemia
  1. Kyle Keinath1,
  2. Tyler Church1,
  3. Brett Sadowski1,
  4. Jeremy Perkins2
  1. 1Internal Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA
  2. 2Hematology-Oncology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA
  1. Correspondence to Dr Kyle Keinath, kyleke{at}pcom.edu

Summary

Renal infarction is a rare occurrence accounting for 0.007% of patients seen in the emergency department for renal insufficiency or hypertension. Dysfibrinogenemia is also rare, and the combination of renal artery infarct in the setting of congenital dysfibrinogenemia has not been described in the literature. Our patient, with a remote history of congenital dysfibrinogenemia with no known haemorrhagic or thrombotic complications, presented with acute flank pain and was subsequently diagnosed with an acute renal arterial infarction. He was treated with subcutaneous enoxaparin and then transitioned to lifelong anticoagulation with rivaroxaban therapy.

  • haematology (incl blood transfusion)
  • renal medicine

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors All authors served as editors of the article. JP and BS served as mentors and advisers. KK and TC took direct care of the patient presented in the case report.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles